Adverse events of special interest possibly/probably related to COVID-19 vaccination among patient with inflammatory RMDs
AE type | Seriousness of AE | Outcome of AE | COVID-19 vaccine | RMD | RMD medication* | Medication held or reduced |
Cardiovascular – arterial hypertension | Non-serious | Recovered/resolved without sequelae | Moderna | axSpA | TNFi | No |
Non-serious | Recovered/resolved without sequelae | AZ | RA | HCQ+GC | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | RA | MTX+GC | No | |
Serious (important medical event) | Recovered/resolved without sequelae | Pfizer | pSpA | GC | No | |
Cardiac – arrhythmia | Non-serious | Recovered/resolved without sequelae | Pfizer | SLE | HCQ+AZA+GC | No |
Non-serious | UNK | Pfizer | RA | GC | Yes | |
Non-serious | Ongoing/continuing | Pfizer | EDS | None | NA | |
Cardiac – coronary artery disease | Serious (life threatening) | Recovered/resolved without sequelae | Pfizer | RA | ABA+MTX+GC | No |
Serious (life threatening) | Recovered/resolved with sequelae | Pfizer | RA | RTX+LEF+GC | No | |
Cardiac – myocarditis and pericarditis | Non-serious | Recovered/resolved without sequelae | Pfizer | SLE | None | NA |
Dermatological – eczema, nodes and plaques | Non-serious | Recovered/resolved without sequelae | Pfizer | RA | ABA | No |
Non-serious | Recovered/resolved without sequelae | Moderna | SjS | HCQ+GC | Yes | |
Non-serious | Ongoing/continuing | AZ | PsA | Apremilast | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | pSpA | TNFi | No | |
Dermatological – pruritus, injection site reaction, redness and burning | Non-serious | Recovered/resolved without sequelae | Pfizer | pSpA | LEF+GC | No |
Non-serious | Ongoing/continuing | Pfizer | RA | MTX+GC | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | PMR | HCQ+GC | No | |
Gastrointestinal – liver injury | Non-serious | Recovered/resolved without sequelae | Pfizer | GCA | MTX | Yes |
Non-serious | Ongoing/continuing | Pfizer | RP | AZA+GC | No | |
Serious (life threatening) | Recovered/resolved with sequelae | Pfizer | SLE | HCQ+GC | No | |
General conditions – hot flush, anxiety, lowered body temperature, loss and lack of appetite and night sweats | Non-serious | Recovered/resolved without sequelae | Pfizer | SSc | MMF+GC | No |
Non-serious | Recovered/resolved without sequelae | AZ | axSpA | TNFi | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | RA | IL-6 | UNK | |
Non-serious | Recovered/resolved without sequelae | Pfizer | PsA | IL-17 | Yes | |
Non-serious | Recovered/resolved without sequelae | Pfizer | GCA | None | NA | |
Non-serious | Recovered/resolved without sequelae | AZ | RA | ABA+MTX | No | |
Non-serious | Recovered/resolved without sequelae | Moderna | RA | None | NA | |
Non-serious | Ongoing/continuing | AZ | axSpA | TNFi | No | |
Haematological – peripheral deep vein thrombosis | Non-serious | Ongoing/continuing | Pfizer | axSpA | IL-17 | No |
Serious (hospitalisation) | Ongoing/continuing | Pfizer | AAV | AZA+GC | No | |
Haematological – haemorrhagic disease | Non-serious | Recovered/resolved without sequelae | AZ | RA | HCQ+GC | No |
Haematological – stroke | Serious (Hospitalisation) | Recovered/resolved with sequelae | Pfizer | PMR | IL-6+GC | No |
Haematological – thrombocytopenia | Non-serious | Recovered/resolved without sequelae | AZ | mCTD | None | NA |
Immunological – anaphylaxis | Non-serious | Recovered/resolved without sequelae | Pfizer | RA | MTX | No |
Non-serious | Recovered/resolved without sequelae | Pfizer | SSc | Sildenafil | No | |
Non-serious | Recovered/resolved without sequelae | AZ | Other vasculitis | GC | Yes | |
Immunological – arthritis | Non-serious | Recovered/resolved without sequelae | AZ | SjS | HCQ | No |
Non-serious | Recovered/resolved without sequelae | Pfizer | PMR | HCQ+GC | No | |
Non-serious | UNK | AZ | GCA | IL-6+GC | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | SLE | HCQ+Belimumab | No | |
Immunological – skin or mucosal | Non-serious | Recovered/resolved without sequelae | Pfizer | SLE | AZA+GC | No |
Non-serious | Recovered/resolved without sequelae | Pfizer | axSpA | SSZ+GC+NSAIDs | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | Myositis | HCQ+MTX+GC | No | |
Non-serious | Ongoing/continuing | Moderna | SjS | None | NA | |
Serious (hospitalisation) | Recovered/resolved without sequelae | Pfizer | PsA | None | NA | |
Serious (important medical event) | Recovered/resolved without sequelae | Pfizer | RA | ABA+HCQ | No | |
Serious (important medical event) | Recovered/resolved without sequelae | AZ | u-CTD | HCQ | No | |
Serious (important medical event) | Ongoing/continuing | Pfizer | PsA | TNFi | No | |
Immunological – vasculitides | Non-serious | Recovered/resolved without sequelae | Pfizer | PsA | IL-17 | Yes |
Lymphadenopathy | Non-serious | Recovered/resolved without sequelae | Pfizer | PsA | IL-17+MTX | No |
Non-serious | Recovered/resolved without sequelae | Moderna | mCTD | None | NA | |
Non-serious | Recovered/resolved without sequelae | Pfizer | Other vasculitis | None | NA | |
Non-serious | Ongoing/continuing | Pfizer | RA | MTX | No | |
Malaise, fatigue and insomnia | Non-serious | Recovered/resolved without sequelae | AZ | PMR | MTX+GC | No |
Non-serious | Recovered/resolved with sequelae | AZ | Monogenic AIS | Colchicine | No | |
Serious (important medical event) | Ongoing/continuing | Pfizer | SSc | MMF | Yes | |
UNK | UNK | Pfizer | PsA | None | NA | |
UNK | UNK | Pfizer | PsA | TNFi+NSAIDs | No | |
Neurological – anosmia and ageusia | Non-serious | Recovered/resolved without sequelae | Pfizer | SjS | MTX | No |
Neurological – drowsiness, vertigo, dizziness, nausea, tinnitus, migraine, hallucination and hemiparesis | Non-serious | Ongoing/continuing | Pfizer | Sarcoidosis | HCQ | No |
Non-serious | Recovered/resolved without sequelae | Unknown | Other IA | HCQ+GC | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | pSpA | Apremilast | No | |
Non-serious | Recovered/resolved without sequelae | AZ | pSpA | IL-17 | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | PsA | IL-17 | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | axSpA | IL-17 | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | SjS | MTX | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | PsA | MTX | No | |
Non-serious | Recovered/resolved without sequelae | Moderna | RA | SSZ | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | axSpA | TNFi | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | Non-systemic JIA | TNFi | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | axSpA | TNFi | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | PsA | TNFi | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | axSpA | TNFi | Yes | |
Non-serious | Recovered/resolved without sequelae | Moderna | pSpA | None | NA | |
Non-serious | Recovered/resolved without sequelae | Pfizer | PsA | IL-12/23 | No | |
Non-serious | Ongoing/continuing | AZ | PsA | None | NA | |
Non-serious | Recovered/resolved without sequelae | AZ | RA | SSZ | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | RA | MTX | Yes | |
Non-serious | Recovered/resolved without sequelae | Pfizer | SSc | Unknown | NA | |
Serious (important medical event) | Ongoing/continuing | Pfizer | SSc | HCQ+MMF | No (HCQ), UNK (MMF) | |
Other possible cardiac symptoms – ankle oedema, dyspnoea and dry cough | Non-serious | Recovered/resolved without sequelae | Pfizer | PsA | IL-17 | No |
Non-serious | Recovered/resolved without sequelae | Moderna | RA | IL-6 | No | |
Non-serious | Recovered/resolved with sequelae | Pfizer | AAV | Benralizumab | No | |
Non-serious | Ongoing/continuing | Moderna | RA | RTX+GC | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | RA | JAKi +GC | Yes (GC), No (JAKi) | |
Serious (important medical event) | Recovered/resolved without sequelae | Pfizer | SjS | HCQ | No | |
UNK | UNK | Pfizer | RA | TNFi | No | |
Pain/pain syndromes | Non-serious | UNK | Pfizer | SjS | None | NA |
Non-serious | Recovered/resolved without sequelae | Pfizer | PMR | GC | UNK | |
Tendons and joints – tendinopathy, frozen shoulder and carpal tunnel syndrome | Non-serious | UNK | Pfizer | RA | ABA+MTX | No |
Non-serious | Ongoing/continuing | Moderna | uCTD | None | NA | |
Non-serious | Ongoing/continuing | Pfizer | PMR | GC | No | |
UNK | UNK | AZ | RA | MTX | No | |
Viral infections – herpes, herpes zoster and shingles | Non-serious | Ongoing/continuing | Pfizer | SjS | HCQ | No |
Non-serious | Ongoing/continuing | Moderna | RA | JAKi | No | |
Non-serious | Ongoing/continuing | Pfizer | RA | JAKi | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | axSpA | TNFi | No | |
Non-serious | Ongoing/continuing | Pfizer | PMR | GC | No | |
Non-serious | Recovered/resolved with sequelae | AZ | RA | TNFi | No | |
Serious (hospitalisation) | Recovered/resolved without sequelae | Pfizer | RA | JAKi | Yes | |
Serious (hospitalisation) | UNK | Pfizer | RA | MTX+GC | Yes (MTX), No (GC) | |
Serious (important medical event) | Recovered/resolved without sequelae | Pfizer | RA | MTX+GC | No | |
Viral infections – influenza, flu-like episodes, rhinitis, cough and cold | Non-serious | Recovered/resolved without sequelae | Pfizer+AZ | GCA | IL-6 | No |
Non-serious | Recovered/resolved without sequelae | Pfizer | Myositis | MTX | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | RA | MTX | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | RA | RTX+MTX | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | axSpA | TNFi | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | CRMO | TNFi+MTX | No | |
Non-serious | Recovered/resolved without sequelae | Pfizer | SjS | None | NA | |
Other – GORD | Non-serious | Recovered/resolved without sequelae | Pfizer | RA | LEF | No |
Other – neck swelling | Serious (hospitalisation) | Recovered/resolved without sequelae | Pfizer | RA | LEF | No |
Other (UNK) | Non-serious | UNK | Pfizer | RA | JAKi+LEF+GC | No |
*Immunosuppressive or immunomodulatory medication.
AAV, ANCA-associated vasculitis; ABA, abatacept; AE, adverse event; AIS, autoinflammatory syndrome; axSpA, axial spondyloarthritis; AZ, Oxford/AstraZeneca; AZA, azathioprine; CRMO, chronic recurrent multifocal osteomyelitis; EDS, Ehlers-Danlos syndrome; GC, glucocorticoids; GCA, giant cell arteritis; GORD, gastro-oesophageal reflux disease; HCQ, hydroxychloroquine; IA, inflammatory arthritis; IL-6, interleukin-6; IL-17, interleukin-17; IL-12/23, interleukin-12/23; JAKi, Janus kinase inhibitors; JIA, juvenile idiopathic arthritis; LEF, leflunomide; mCTD, mixed connective tissue disease; MMF, mycophenolate mofetil/mycophenolic acid; MTX, methotrexate; NSAIDs, nonsteroidal anti-inflammatory drugs; PMR, polymyalgia rheumatica; PsA, psoriatic arthritis; pSpA, peripheral spondyloarthritis; RA, rheumatoid arthritis; RMD, rheumatic and musculoskeletal disease; RP, relapsing polychondritis; RTX, rituximab; SjS, Sjogren’s syndrome; SLE, systemic lupus erythematosus; SpA, spondyloarthritis; SSc, systemic sclerosis; SSZ, sulfasalazine; TNFi, tumour necrosis factor; uCTD, undifferentiated connective tissue disease; UNK, unknown/missing.